Products billed under this code include Bactocill In Dextrose, Oxacillin Sodium.
Payment limit per 250 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Bactocill In Dextrose | Baxter Healthcare Corporation | 00338-1015-41 | 8 | $6.144 |
| Oxacillin Sodium | Sagent Pharmaceuticals | 25021-0146-10 | 40 | $30.72 |
| Oxacillin Sodium | Sagent Pharmaceuticals | 25021-0162-24 | 80 | $61.44 |
| Oxacillin Sodium | Sagent Pharmaceuticals | 25021-0162-68 | 80 | $61.44 |
| Oxacillin Sodium | Sagent Pharmaceuticals | 25021-0163-68 | 400 | $307.20 |
| Oxacillin Sodium | Sagent Pharmaceuticals | 25021-0163-97 | 40 | $30.72 |
| Oxacillin Sodium | Sagent Pharmaceuticals | 25021-0163-99 | 400 | $307.20 |
| Oxacillin Sodium | Eugia US LLC | 55150-0127-15 | 40 | $30.72 |
| Oxacillin Sodium | Eugia US LLC | 55150-0128-24 | 80 | $61.44 |
| Oxacillin Sodium | Eugia US LLC | 55150-0129-99 | 40 | $30.72 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Oxacillin Sodium | FreseniUS Kabi USA, LLC | 63323-0811-00 | 40 | $30.72 |
| Oxacillin Sodium | FreseniUS Kabi USA, LLC | 63323-0812-20 | 80 | $61.44 |
| Oxacillin Sodium | FreseniUS Kabi USA, LLC | 63323-0813-20 | 40 | $30.72 |
| Oxacillin Sodium | Armas Pharmaceuticals Inc. | 72485-0409-10 | 80 | $61.44 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.768 | +$0.005 | 250 MG | Oxacillin sodium injeciton | v1, posted September 17, 2026 |
| 3Q26 | $0.763 | −$0.091 | 250 MG | Oxacillin sodium injeciton | v1, posted September 15, 2026 |
| 2Q26 | $0.854 | +$0.285 | 250 MG | Oxacillin sodium injeciton | v1, posted September 15, 2026 |
| 1Q26 | $0.569 | −$0.218 | 250 MG | Oxacillin sodium injeciton | v1, posted September 15, 2026 |
| 4Q25 | $0.787 | −$0.035 | 250 MG | Oxacillin sodium injeciton | v1, posted September 8, 2026 |
| 3Q25 | $0.822 | +$0.186 | 250 MG | Oxacillin sodium injeciton | v1, posted March 10, 2026 |
| 2Q25 | $0.636 | −$0.429 | 250 MG | Oxacillin sodium injeciton | v1, posted March 10, 2026 |
| 1Q25 | $1.065 | +$0.198 | 250 MG | Oxacillin sodium injeciton | v1, posted December 19, 2025 |
| 4Q24 | $0.867 | −$0.072 | 250 MG | Oxacillin sodium injeciton | v1, posted June 11, 2025 |
| 3Q24 | $0.939 | −$0.186 | 250 MG | Oxacillin sodium injeciton | v1, posted June 11, 2025 |
| 2Q24 | $1.125 | +$0.077 | 250 MG | Oxacillin sodium injeciton | v1, posted March 11, 2025 |
| 1Q24 | $1.048 | +$0.074 | 250 MG | Oxacillin sodium injeciton | v1, posted December 19, 2024 |
| 4Q23 | $0.974 | −$0.199 | 250 MG | Oxacillin sodium injeciton | v1, posted October 10, 2024 |
| 3Q23 | $1.173 | +$0.10 | 250 MG | Oxacillin sodium injeciton | v1, posted June 5, 2024 |
| 2Q23 | $1.073 | −$0.211 | 250 MG | Oxacillin sodium injeciton | v1, posted February 23, 2024 |
| 1Q23 | $1.284 | +$0.053 | 250 MG | Oxacillin sodium injeciton | v1, posted December 6, 2023 |
| 4Q22 | $1.231 | +$0.191 | 250 MG | Oxacillin sodium injeciton | v1, posted June 22, 2023 |
| 3Q22 | $1.04 | −$0.018 | 250 MG | Oxacillin sodium injeciton | v1, posted June 9, 2023 |
| 2Q22 | $1.058 | −$0.223 | 250 MG | Oxacillin sodium injeciton | v1, posted December 14, 2022 |
| 1Q22 | $1.281 | +$0.001 | 250 MG | Oxacillin sodium injeciton | v1, posted June 8, 2022 |
| 4Q21 | $1.28 | +$0.015 | 250 MG | Oxacillin sodium injeciton | v1, posted June 2, 2022 |
| 3Q21 | $1.265 | −$0.02 | 250 MG | Oxacillin sodium injeciton | v1, posted June 2, 2022 |
| 2Q21 | $1.285 | +$0.062 | 250 MG | Oxacillin sodium injeciton | v1, posted March 1, 2022 |
| 1Q21 | $1.223 | – | 250 MG | Oxacillin sodium injeciton | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
